SURVIVAL AND DEATH RISK OF PATIENTS WITH PROSTATE CANCER TREATED IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
Author(s)
Mendes Braga S1, Souza MC2, Oliveira RR3, Andrade EI3, Acurcio Fd4, Cherchiglia ML3
1Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 2Instituto Nacional do Câncer, Rio de Janeiro, Brazil, 3Federal University of Minas Gerais, Belo Horizonte, Brazil, 4College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil
OBJECTIVES: Analyze the 5 year specific survival and the associated factors to the risk of death among prostate cancer patients, treated in Unified Health System, from 2002 to 2003 in Brazil METHODS: A retrospective study which used as a data source to "National Base in Oncology", developed by deterministic-probabilistic linkage of health information systems: outpatient (SIA), Hospital (SIH) and mortality (SIM). The likelihood of overall and specific survival was estimated by the time elapsed between the date of the first outpatient treatment until patient death or end of study. We used the regression model for competing risks of Fine & Gray in the estimation of specific factors associated with survival of patients diagnosed with prostate cancer in Brazil. RESULTS: From 16.280 patients studied, the mean age was 70 years, about 25% died from prostate cancer and 20% from other causes. The global survival probability was 0,50 and specific 0,70. The associated factors to the death risk of patients were age when diagnosed, stages III and IV, chemotherapy and hospitalization. CONCLUSIONS: The death risk of these patients could be diminished by improvements in the access to cancer diagnosis and early treatment, as well as by preventive measures which aim to improve the general health of men in the country, especially the elderly who live with other diseases besides tumor.
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PHS113
Topic
Health Policy & Regulatory, Real World Data & Information Systems
Topic Subcategory
Health & Insurance Records Systems, Health Disparities & Equity
Disease
Oncology